ChainCatcher news, Nasdaq-listed company Qualigen Therapeutics (QLGN) announced that over the past two weeks it has completed the setup of basic infrastructure such as US dollar cash settlement, bank accounts, and cryptocurrency custody accounts. The company will officially begin purchasing its first batch of strategic assets this week, mainly investing in the top 10 cryptocurrencies by market capitalization, with a focus on "blue-chip" crypto assets such as BNB, ETH, and SOL.
Previous reports stated that FF has made a strategic investment of $41 million in Nasdaq-listed company QLGN, and Jia Yueting invested $4 million. QLGN will be renamed CXC 10.